Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-54.06	17.27	37.59
Graham Fair Price	41.58	1.09	0.77
PEG	-60.73	0.67	-1.70
Price/Book	-21.26	0.34	0.43
Price/Cash Flow	101.27	-39.28	19.52
Prices/Earnings	-60.63	64.99	165.06
Price/Sales	-60.63	2.21	5.62
Price/FCF	101.27	-39.28	19.52
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-0.70	0.42	0.42
Operating Margin	-0.40	0.32	0.32
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	284.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	-0.03	-18.08
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.70	0.99	41.13
EPS QOQ	-0.97	0.98	0.25
FCF QOQ	1.31	-1.39	6.12
Revenue QOQ	-0.60	1.00	65.59
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	10.11	5.03	-50.25
Days Sales Outstanding (DSO)	774.51	394.38	-49.08
Inventory Turnover	8.90	17.90	101.01
Debt/Capitalization	0.68	0.66	-2.95
Quick Ratio	1.24	1.27	2.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	6.40	6.41	0.11
Cash	2.42	2.53	4.66
Capex	-0.14	-0.31	-130.80
Free Cash Flow	0.14	-0.05	-60.83
Revenue	0.49	0.98	100.23
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.54	1.54	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	30.45	14.61	-52.01
Naive Interpretation	Member

06 - Financial Health · Weak

Rating